| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 65,127 | 65,963 | 55,353 | 75,060 | | Cost of Revenue | 40,160 | 39,232 | 42,298 | 47,731 | | | Gross Profit | 24,967 | 26,731 | 13,055 | 27,329 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,270 | 4,686 | 6,577 | 5,394 | | Non Recurring | 180,289 | (7,204) |
-
| 498,963 | | Others | 2,650 | 2,817 | 2,898 | 3,126 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (160,054) | 26,432 | 3,580 | (480,154) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,070 | (29) | 49 | 105 | | Earnings Before Interest And Taxes | (160,172) | 26,403 | 3,629 | (480,049) | | Interest Expense | 11,052 | 6,213 | 7,783 | 19,454 | | Income Before Tax | (171,224) | 20,190 | (4,154) | (499,503) | | Income Tax Expense | (27,233) | 6,115 | (858) | (129,725) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (143,991) | 14,075 | (3,296) | (393,717) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (143,991) | 14,075 | (3,296) | (393,717) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($143,991) | $14,075 | ($3,296) | ($393,717) |
|
0.51% Nasdaq 
Income Statement
